General Characteristics and Core Mechanism
The cytotoxic type is based on the production of antibodies (primarily IgG and IgM) directed against antigens located on the cell surface. These antigens can be intrinsic membrane components (endogenous) or external agents, such as drugs that act as haptens and firmly bind to the cell wall.
When antibodies recognize the antigen, a cascade of effector mechanisms designed to destroy the resulting complex is triggered. This leads to the destruction (cytolysis) of the target cell.
In some cases, anti-receptor reactions (previously classified as Type V) are also included in this category, as their essence likewise involves the interaction of antibodies with cellular structures—specifically, receptors.
Pathogenesis: How the Cell Dies
Destruction of the target cell can occur via one of three main pathways:
- Complement-dependent cytolysis. The antibody binds to the membrane antigen, after which its Fc region activates the complement system via the classical pathway. This process generates anaphylatoxins (C3a, C5a) and forms the membrane attack complex (MAC). The MAC literally punches holes in the cell membrane, causing cell death.
- Phagocytosis (Opsonization). The target cell becomes coated with antibody molecules and complement components (specifically C3b). Phagocytes easily recognize such "prepared" (opsonized) cells, engulf, and digest them.
- Antibody-dependent cellular cytotoxicity (ADCC). In this case, natural killer (NK) cells play the primary role. They recognize the Fc regions of antibodies already attached to the cell and release toxic enzymes (perforins and granzymes). This results in lysis without the participation of the complement system.
Clinical Manifestations
Depending on which tissues the autoantibodies target, various pathologies develop:
- Hematologic disorders. In autoimmune hemolytic anemia, antibodies attack erythrocyte Rh antigens, leading to their phagocytosis and complement-mediated destruction. In drug-induced cytopenias, medications act as haptens, resulting in blood cell lysis (anemia, thrombocytopenia, granulocytopenia).
- Structural tissue damage. In pemphigus vulgaris, antibodies attack cell adhesion molecules, causing blistering due to the loss of intercellular adhesion. In Goodpasture syndrome, the target is the basement membrane of alveoli and renal glomeruli, causing hemoptysis and nephritis.
- Anti-receptor diseases. Antibodies may not destroy the cell but rather disrupt its function. In myasthenia gravis, antibodies block acetylcholine receptors, causing muscle weakness. In Graves' disease (thyrotoxicosis), antibodies stimulate TSH receptors, forcing the thyroid gland into overdrive.
Diagnostic Principles
Laboratory diagnostics are based on confirming the presence of specific antibodies in the patient's tissues or blood.
Two main approaches are used:
- Searching for circulating antitissue antibodies in blood serum.
- Examining biopsy specimens from affected areas using direct immunofluorescence (IF). This method visualizes deposits of complement components and antibodies directly within the tissues.